Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Track PCRX with free AI briefings, catalyst countdowns, and dilution alerts.

PCRX · Pacira BioSciences, Inc.

Company guidance, FDA catalysts, dilution risk and cash runway, built from SEC, FDA and ClinicalTrials.gov filings and updated every day.

$295.6M Cash on Hand
CF+ Cash Runway
Follow PCRX by email Get an email when PCRX reports key news in an SEC filing, pushes back a promised milestone, files for a stock offering, lands on the Downside Radar or has an FDA decision. Free, no account needed.

We send one confirmation email first. Only emails about PCRX, unsubscribe in one click. Privacy

📣 What PCRX Says Is Next

Quoted word for word from the company's press releases filed with the SEC. Timing is the company's own guidance, not a BioRadar estimate.

📄 Latest SEC Filings in Plain English

Each summary is written by AI from the filing itself, and one that names a number or a name the filing does not contain is not shown. Quarterly and annual reports are listed by period. Read the filing before acting on it.

🧪 Trial & FDA Catalysts

📊 Drug Pipeline

DrugIndicationMost advanced trialStatus
Bupivacaine
FDA approved Oct 2011 · Exparel
Laparotomy Phase 4 · NCT03827291 Completed
Liposomal Bupivacaine Total Knee Arthroplasty Phase 4 · NCT07584915 Enrolling by invitation
Continuous popliteal nerve block with… Moderate-to-severely Painful Ankle Surgery Phase 4 · NCT06995352 Enrolling by invitation
Bupivacaine supraclavicular block Hand Injuries Phase 4 · NCT02058303 Terminated
Ketorolac Pain Phase 4 · NCT02128646 Completed
Methadone Adolescent Idiopathic Scoliosis Phase 4 · NCT05730920 Completed
Popliteal nerve block including liposomal… Moderate-to-severely Painful Ankle Surgery Phase 4 · NCT06995352 Enrolling by invitation
Popliteal nerve block with exclusively… Moderate-to-severely Painful Ankle Surgery Phase 4 · NCT06995352 Enrolling by invitation
Adductor canal nerve block with exclusively… Moderate-to-severely Painful Ankle Surgery Phase 4 · NCT06995352 Enrolling by invitation
Adductor canal nerve block including liposomal… Moderate-to-severely Painful Ankle Surgery Phase 4 · NCT06995352 Enrolling by invitation
Ropivacaine Rotator Cuff Injury Phase 4 · NCT03738696 Completed
0.25% bupivacaine (HCl): 30 ml Total Ankle Arthroplasty Phase 3 · NCT07212114 Recruiting
FX006 Osteoarthritis of the Knee Phase 3 · NCT03046446 Completed
Triamcinolone Acetonide Extended-Release… Osteoarthritis of the Knee Phase 3 · NCT02357459 Completed
Bupivacain Back Pain Phase 2/3 · NCT06350981 Enrolling by invitation
Bupivacaine Hydrochloride Pain, Postoperative Phase 2/3 · NCT06077422 Enrolling by invitation

Also used in these trials (approved or third-party drugs, not PCRX's own candidates): Triamcinolone Acetonide, Duloxetine, Acetaminophen, Celecoxib.

Source: ClinicalTrials.gov trials sponsored by the company, one row per candidate at its most advanced registered trial. FDA approvals: Drugs@FDA. Wrong or missing drug? Report it

💰 Cash Runway & Dilution Risk

PCRX holds $295.6M in cash and short-term investments (as of Sep 30, 2026) and its operations are currently cash-flow neutral or positive.

Source: SEC EDGAR (XBRL cash flow and financing filings). Dilution Watch: every company ranked → · Get an alert when PCRX files for a raise →

Get the full PCRX picture

The 7-day free trial adds AI daily briefings, sentiment tracking, trial enrollment progress and email alerts for PCRX and every other ticker you follow. Card required, cancel anytime.

Start 7-day free trial →

Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.